We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $19.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
9% more capital invested
Capital invested by funds: $18.1M → $19.7M (+$1.57M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$63.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$38.2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.97K |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$193K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5K |